OncRef

Clinical Trial: NCT07862114

A Study to Investigate the Effect of Omeprazole and Cyclosporine on Velzatinib in Healthy Participants

Status:

NOT YET RECRUITING

Phase:

Phase 1

Lead Sponsor:GlaxoSmithKline
Information Provided By:GlaxoSmithKline
Last Update Posted:2026-10-07

Study Overview

Brief Summary

This study will look at how two commonly used medicines, omeprazole and cyclosporine, influence the way the body absorbs, processes, and eliminates velzatinib in healthy volunteers.

Official Title

A Phase 1 Non-Randomized, Open-Label, Parallel-Group Study to Investigate the Effects of Coadministration of the Proton Pump Inhibitor Omeprazole or the P-gp/BCRP Inhibitor Cyclosporine on the Pharmacokinetics, Safety, and Tolerability of Velzatinib in Healthy Participants

Conditions

Healthy Participants, Gastrointestinal Neoplasms

Intervention / Treatment

  • Drug: Velzatinib
  • Drug: Cyclosporine
  • Drug: Omeprazole

Other Study ID Numbers

  • 301002

Start Date (Estimated)

2026-10-16

Primary Completion Date (Estimated)

2027-01-12

Study Completion Date (Estimated)

2027-01-12

Enrollment (Estimated)

36

Study Type

Interventional

Phase

Phase 1